Additional details will be posted soon...
DON'T MISS THE ONLY CADAVER BASED HANDS-ON PCNL COURSE OF 2019!Directed by Ralph V. Clayman, MD and Jaime Landman, MD, this newly enhanced course will feature a combination of didactic lectures, surgical video cases, panel discussions, Q & A sessions, an interactive review using audience response and hands-on surgical skill stations that allow each participant to perform percutaneous stone removal from start to finish on human cadavers for more accurate training.
Celebrate SUFU's 50th Anniversary!
Online registration is NOW OPEN for the SUFU 2019 Winter Meeting, February 26 - March 2, 2019! The registration discount will be available until January 28, 2019!
The 2019 Winter Meeting will celebrate the 50th Anniversary of SUFU. Join SUFU in Miami to toast this special event and stay for the dynamic and interactive program sessions. The 2019 program will continue the tradition of presenting the most current and collaborative information you won't want to miss!
Please check the SUFU website often for updates on the scientific program, accreditation and other meeting-related information.
We look forward to seeing you all in Florida!
Leaders from academia and industry, clinicians, researchers, and regulators work together to speed up the development of new anti-cancer treatments for better patient outcomes.
The TAT Congress series has been at the forefront of revolutionary transformation in early drug development and has succeeded in broadening the conversation on phase I trials to include a wide circle of stakeholders.
Participating in TAT 2019 will put you at the heart of discussions shaping the most promising paths for developing new therapeutics. Take the opportunity to shape the future of drug development together with the world’s most renowned experts.
Free Daily and Weekly newsletters offered by content of interest
The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.